Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretics for Malignant Ascites
NCT02501213Phase 2Terminated
- Sponsor
- Centre Oscar Lambret
- Start
- May 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone, furosemide in malignant ascites, sponsored by Centre Oscar Lambret. Started May 2016; status: terminated.
02
Drugs
spironolactonefurosemide
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT02501213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02501213.